Using experimental results of protein design to guide biomolecular energy-function development
Haddox, Hugh K., Gabriel J. Rocklin, Francis C. Motta et al · PLOS Computational Biology
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
786 of the project's 1 307 629 users with RAC have a Gridcoin CPID, but together they bring only 0.1 % of its credit rate, and it is greylisted: the chain pays no magnitude for it while it is.
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
Designs new proteins and predicts the three-dimensional shape of proteins.
Run by the University of Washington (the Baker Lab). Rosetta is a program for protein design and structure prediction. Lately the project has also been used for the design of small molecules and peptides and for virtual screening in drug discovery, where artificial intelligence models still have trouble.
Haddox, Hugh K., Gabriel J. Rocklin, Francis C. Motta et al · PLOS Computational Biology
Baek, Minkyung, Ryan McHugh, Ivan Anishchenko, Hanlun Jiang, David Baker and Frank DiMaio · Nature Methods
Vázquez Torres, Susana, Philip J. Y. Leung, Preetham Venkatesh et al · Nature
RAC of the Gridcoin users per superblock, plus the rest of the project where known
The accounts of the CPIDs in each superblock
GRC a day for a million RAC: the project's share of the magnitude over its Gridcoin RAC
235 publications
| Year | Paper | Sub-project | Published in |
|---|---|---|---|
| 2026 | Using experimental results of protein design to guide biomolecular energy-function developmentHaddox, Hugh K., Gabriel J. Rocklin, Francis C. Motta et al | – | PLOS Computational Biology |
| 2024 | Accurate prediction of protein–nucleic acid complexes using RoseTTAFoldNABaek, Minkyung, Ryan McHugh, Ivan Anishchenko, Hanlun Jiang, David Baker and Frank DiMaio | – | Nature Methods |
| 2024 | De novo design of high-affinity binders of bioactive helical peptidesVázquez Torres, Susana, Philip J. Y. Leung, Preetham Venkatesh et al | – | Nature |
| 2024 | Computational design of soluble and functional membrane protein analoguesGoverde, Casper A., Martin Pacesa, Nicolas Goldbach et al | – | Nature |
| 2024 | Accurate de novo design of heterochiral protein–protein interactionsSun, Ke, Sicong Li, Bowen Zheng et al | – | Cell Research |
| 2024 | Massively parallel measurement of protein–protein interactions by sequencing using MP3-seqBaryshev, Alexandr, Alyssa La Fleur, Benjamin Groves, Cirstyn Michel, David Baker, Ajasja Ljubetič and Georg Seelig | – | Nature Chemical Biology |
| 2024 | Improving Protein Expression, Stability, and Function with ProteinMPNNSumida, Kiera H., Reyes Núñez-Franco, Indrek Kalvet et al | – | Journal of the American Chemical Society |
| 2024 | Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolutionZhang, Jason Z., William H. Nguyen, Nathan Greenwood, John C. Rose, Shao-En Ong, Dustin J. Maly and David Baker | – | Nature Biotechnology |
| 2024 | De novo design of modular protein hydrogels with programmable intra- and extracellular viscoelasticityMout, Rubul, Ross C. Bretherton, Justin Decarreau et al | – | Proceedings of the National Academy of Sciences |
| 2024 | Generalized biomolecular modeling and design with RoseTTAFold All-AtomKrishna, Rohith, Jue Wang, Woody Ahern et al | – | Science |
| 2024 | Blueprinting extendable nanomaterials with standardized protein blocksHuddy, Timothy F., Yang Hsia, Ryan D. Kibler et al | – | Nature |
| 2024 | Design of amyloidogenic peptide trapsSahtoe, Danny D., Ewa A. Andrzejewska, Hannah L. Han et al | – | Nature Chemical Biology |
| 2024 | Protein Ensemble Generation Through Variational Autoencoder Latent Space SamplingMansoor, Sanaa, Minkyung Baek, Hahnbeom Park, Gyu Rie Lee and David Baker | – | Journal of Chemical Theory and Computation |
| 2024 | De novo design of pH-responsive self-assembling helical protein filamentsShen, Hao, Eric M. Lynch, Susrut Akkineni et al | – | Nature Nanotechnology |
| 2024 | Expansive discovery of chemically diverse structured macrocyclic oligoamidesSalveson, Patrick J., Adam P. Moyer, Meerit Y. Said et al | – | Science |
| 2024 | Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein PeptidaseCraven, Timothy W., Mark D. Nolan, Jonathan Bailey et al | – | ACS Chemical Biology |
| 2024 | Computational design of non-porous pH-responsive antibody nanoparticlesYang, Erin C., Robby Divine, Marcos C. Miranda et al | – | Nature Structural & Molecular Biology |
| 2024 | De novo design of buttressed loops for sculpting protein functionsJiang, Hanlun, Kevin M. Jude, Kejia Wu et al | – | Nature Chemical Biology |
| 2024 | Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesEdman, Natasha I., Ashish Phal, Rachel L. Redler et al | – | Cell |
| 2024 | Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsBerger, Stephanie, Franziska Seeger, Ta-Yi Yu et al | – | Cell |
| 2024 | De novo design of allosterically switchable protein assembliesPillai, Arvind, Abbas Idris, Annika Philomin et al | – | Nature |
| 2024 | De novo design of miniprotein antagonists of cytokine storm inducersHuang, Buwei, Brian Coventry, Marta T. Borowska et al | – | Nature Communications |
| 2024 | Protein interactions in human pathogens revealed through deep learningHumphreys, Ian R., Jing Zhang, Minkyung Baek et al | – | Nature Microbiology |
| 2024 | Multistate and functional protein design using RoseTTAFold sequence space diffusionLisanza, Sidney Lyayuga, Jacob Merle Gershon, Samuel W. K. Tipps et al | – | Nature Biotechnology |
| 2024 | Designed endocytosis-inducing proteins degrade targets and amplify signalsHuang, Buwei, Mohamad Abedi, Green Ahn et al | – | Nature |
| 2024 | Design of pseudosymmetric protein hetero-oligomersKibler, Ryan D., Sangmin Lee, Madison A. Kennedy et al | – | Nature Communications |
| 2024 | Hierarchical design of pseudosymmetric protein nanocagesDowling, Quinton M., Young-Jun Park, Chelsea N. Fries et al | – | Nature |
| 2024 | An artificial intelligence accelerated virtual screening platform for drug discoveryZhou, Guangfeng, Domnita-Valeria Rusnac, Hahnbeom Park et al | – | Nature Communications |
| 2023 | Design of Diverse Asymmetric Pockets in De Novo Homo-oligomeric ProteinsGerben, Stacey R, Andrew J Borst, Derrick R Hicks et al | – | Biochemistry |
| 2023 | Peptide-binding specificity prediction using fine-tuned protein structure prediction networksMotmaen, Amir, Justas Dauparas, Minkyung Baek, Mohamad H. Abedi, David Baker and Philip Bradley | – | Proceedings of the National Academy of Sciences |
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.
Advertisement
We understand ads are no fun, but they are what makes Gridcoinstats possible.
No ad to show here right now. We understand ads are no fun, but they are what makes Gridcoinstats possible.
The ads are blocked in your browser. We understand ads are no fun, but they are what makes Gridcoinstats possible.